BTIG initiated coverage on Endologix (NASDAQ: ELGX) with a Buy rating and price target of $21.00.

Analyst Sean Lavin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE